Glucose Level Management in Non-Diabetic Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of adjusting insulin delivery rates to manage glucose levels in various non-diabetic applications, including livestock feed optimization, personalized nutrition planning, real-time glucose monitoring in athletes, crop yield optimization, and hypoglycemia prevention in patients undergoing anesthesia.
Background and Problem Solved
The original patent focused on adjusting insulin delivery rates for diabetes management. However, glucose level management is crucial in other fields as well. For instance, in livestock farming, glucose level variations can impact animal health and productivity. Similarly, in athletes, real-time glucose monitoring can improve performance and prevent hypoglycemia. This inventive concept addresses these unmet needs by applying the core technology to new industries and use cases.
Detailed Description of the Inventive Concept
The new claims describe systems and methods that utilize glucose measurement devices, models for predicting future glucose levels, and controllers for adjusting various parameters to minimize glucose level variations. For example, in livestock feed optimization, the system adjusts feed composition to maintain optimal glucose levels. In personalized nutrition planning, the model predicts glucose responses to different meal compositions and selects the optimal meal plan. In real-time glucose monitoring, the device alerts athletes to take corrective action when glucose levels deviate from a target range. Similarly, in crop yield optimization, the system adjusts irrigation and fertilization schedules to minimize glucose level variations in plants. In hypoglycemia prevention, the system alerts medical staff to take corrective action when glucose levels deviate from a target range during anesthesia.
Novelty and Inventive Step
The new claims introduce a novel application of the core technology to non-diabetic fields, providing an inventive step over the original patent. The specific combination of glucose measurement devices, predictive models, and controllers tailored to each new application is not obvious from the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of glucose measurement devices, such as implantable sensors or non-invasive optical sensors. Variations may also include integrating the glucose level management systems with other technologies, such as machine learning algorithms or IoT devices, to enhance their functionality and accuracy.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including livestock farming, sports and fitness, agriculture, and healthcare. The market size for glucose level management in these industries is substantial, and the inventive concept offers a unique value proposition by providing precise and real-time glucose level management solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/1723 |
| A | A61 | A61B5/14532 |
| A | A61 | A61B5/4839 |
| A | A61 | A61M5/142 |
| A | A61 | A61M5/145 |
| A | A61 | A61M5/14244 |
| A | A61 | A61M5/14248 |
| G | G16 | G16H20/17 |
| G | G16 | G16H40/60 |
| G | G16 | G16H40/67 |
| A | A61 | A61B2562/0295 |
| A | A61 | A61M2005/14208 |
| A | A61 | A61M2205/3303 |
| A | A61 | A61M2205/3553 |
| A | A61 | A61M2205/3561 |
| A | A61 | A61M2205/3569 |
| A | A61 | A61M2205/3584 |
| A | A61 | A61M2205/502 |
| A | A61 | A61M2205/52 |
| A | A61 | A61M2230/005 |
| A | A61 | A61M2230/201 |
| G | G16 | G16H10/60 |
| G | G16 | G16H40/40 |
| G | G16 | G16H50/30 |
Original Patent Information
| Patent Number | US 11,857,763 |
|---|---|
| Title | Adjusting insulin delivery rates |
| Assignee(s) | INSULET CORPORATION |